English
简体中文
Total: £ 56.28
Published Date: 2025-05-02 | Pages: 82 | Tables: 82 | Medical Care
The global market for Virtual Oncology was valued at US$ 3865 million in the year 2024 and is projected to reach a revised size of US$ 8880 million by 2031, growing at a CAGR of 12.8% during the forecast period.
Virtual Oncology generally refers to the use of virtual or digital technologies in the field of oncology, which is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
Teleoncology services, including remote consultations, follow-ups, and monitoring, continue to expand. The use of video conferencing, secure messaging, and other telecommunication tools allows oncology professionals to connect with patients regardless of geographic locations, improving access to care.
This report aims to provide a comprehensive presentation of the global market for Virtual Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Oncology.
The Virtual Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Virtual Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virtual Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
McKesson Corporation
Cerner Corporation
Koninklijke Philips N.V.
Siemens Healthcare Private Limited
Crisp
Varian Medical Systems, Inc.
Elekta AB
Accuray Incorporated
C-TAC Health
Oscar Health
NXGN Management, LLC
Epic Systems Corporation
Optum, Inc
CureMatch, Inc.
Oncora Medical
Segment by Type
Software
Service
Hardware
Segment by Application
Hospitals & Diagnostic Imaging Centers
Academic Institutions & Research Centers
Pharma & Biotech Companies
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Virtual Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software
1.2.3 Service
1.2.4 Hardware
1.3 Market by Application
1.3.1 Global Virtual Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals & Diagnostic Imaging Centers
1.3.3 Academic Institutions & Research Centers
1.3.4 Pharma & Biotech Companies
1.3.5 Contract Research Organizations (CROs)
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virtual Oncology Market Perspective (2020-2031)
2.2 Global Virtual Oncology Growth Trends by Region
2.2.1 Global Virtual Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Virtual Oncology Historic Market Size by Region (2020-2025)
2.2.3 Virtual Oncology Forecasted Market Size by Region (2026-2031)
2.3 Virtual Oncology Market Dynamics
2.3.1 Virtual Oncology Industry Trends
2.3.2 Virtual Oncology Market Drivers
2.3.3 Virtual Oncology Market Challenges
2.3.4 Virtual Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Oncology Players by Revenue
3.1.1 Global Top Virtual Oncology Players by Revenue (2020-2025)
3.1.2 Global Virtual Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Virtual Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Virtual Oncology Revenue
3.4 Global Virtual Oncology Market Concentration Ratio
3.4.1 Global Virtual Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Oncology Revenue in 2024
3.5 Global Key Players of Virtual Oncology Head office and Area Served
3.6 Global Key Players of Virtual Oncology, Product and Application
3.7 Global Key Players of Virtual Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Virtual Oncology Breakdown Data by Type
4.1 Global Virtual Oncology Historic Market Size by Type (2020-2025)
4.2 Global Virtual Oncology Forecasted Market Size by Type (2026-2031)
5 Virtual Oncology Breakdown Data by Application
5.1 Global Virtual Oncology Historic Market Size by Application (2020-2025)
5.2 Global Virtual Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Virtual Oncology Market Size (2020-2031)
6.2 North America Virtual Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Virtual Oncology Market Size by Country (2020-2025)
6.4 North America Virtual Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Virtual Oncology Market Size (2020-2031)
7.2 Europe Virtual Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Virtual Oncology Market Size by Country (2020-2025)
7.4 Europe Virtual Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Virtual Oncology Market Size (2020-2031)
8.2 Asia-Pacific Virtual Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Virtual Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Virtual Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Virtual Oncology Market Size (2020-2031)
9.2 Latin America Virtual Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Virtual Oncology Market Size by Country (2020-2025)
9.4 Latin America Virtual Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virtual Oncology Market Size (2020-2031)
10.2 Middle East & Africa Virtual Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Virtual Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Virtual Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 McKesson Corporation
11.1.1 McKesson Corporation Company Details
11.1.2 McKesson Corporation Business Overview
11.1.3 McKesson Corporation Virtual Oncology Introduction
11.1.4 McKesson Corporation Revenue in Virtual Oncology Business (2020-2025)
11.1.5 McKesson Corporation Recent Development
11.2 Cerner Corporation
11.2.1 Cerner Corporation Company Details
11.2.2 Cerner Corporation Business Overview
11.2.3 Cerner Corporation Virtual Oncology Introduction
11.2.4 Cerner Corporation Revenue in Virtual Oncology Business (2020-2025)
11.2.5 Cerner Corporation Recent Development
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Details
11.3.2 Koninklijke Philips N.V. Business Overview
11.3.3 Koninklijke Philips N.V. Virtual Oncology Introduction
11.3.4 Koninklijke Philips N.V. Revenue in Virtual Oncology Business (2020-2025)
11.3.5 Koninklijke Philips N.V. Recent Development
11.4 Siemens Healthcare Private Limited
11.4.1 Siemens Healthcare Private Limited Company Details
11.4.2 Siemens Healthcare Private Limited Business Overview
11.4.3 Siemens Healthcare Private Limited Virtual Oncology Introduction
11.4.4 Siemens Healthcare Private Limited Revenue in Virtual Oncology Business (2020-2025)
11.4.5 Siemens Healthcare Private Limited Recent Development
11.5 Crisp
11.5.1 Crisp Company Details
11.5.2 Crisp Business Overview
11.5.3 Crisp Virtual Oncology Introduction
11.5.4 Crisp Revenue in Virtual Oncology Business (2020-2025)
11.5.5 Crisp Recent Development
11.6 Varian Medical Systems, Inc.
11.6.1 Varian Medical Systems, Inc. Company Details
11.6.2 Varian Medical Systems, Inc. Business Overview
11.6.3 Varian Medical Systems, Inc. Virtual Oncology Introduction
11.6.4 Varian Medical Systems, Inc. Revenue in Virtual Oncology Business (2020-2025)
11.6.5 Varian Medical Systems, Inc. Recent Development
11.7 Elekta AB
11.7.1 Elekta AB Company Details
11.7.2 Elekta AB Business Overview
11.7.3 Elekta AB Virtual Oncology Introduction
11.7.4 Elekta AB Revenue in Virtual Oncology Business (2020-2025)
11.7.5 Elekta AB Recent Development
11.8 Accuray Incorporated
11.8.1 Accuray Incorporated Company Details
11.8.2 Accuray Incorporated Business Overview
11.8.3 Accuray Incorporated Virtual Oncology Introduction
11.8.4 Accuray Incorporated Revenue in Virtual Oncology Business (2020-2025)
11.8.5 Accuray Incorporated Recent Development
11.9 C-TAC Health
11.9.1 C-TAC Health Company Details
11.9.2 C-TAC Health Business Overview
11.9.3 C-TAC Health Virtual Oncology Introduction
11.9.4 C-TAC Health Revenue in Virtual Oncology Business (2020-2025)
11.9.5 C-TAC Health Recent Development
11.10 Oscar Health
11.10.1 Oscar Health Company Details
11.10.2 Oscar Health Business Overview
11.10.3 Oscar Health Virtual Oncology Introduction
11.10.4 Oscar Health Revenue in Virtual Oncology Business (2020-2025)
11.10.5 Oscar Health Recent Development
11.11 NXGN Management, LLC
11.11.1 NXGN Management, LLC Company Details
11.11.2 NXGN Management, LLC Business Overview
11.11.3 NXGN Management, LLC Virtual Oncology Introduction
11.11.4 NXGN Management, LLC Revenue in Virtual Oncology Business (2020-2025)
11.11.5 NXGN Management, LLC Recent Development
11.12 Epic Systems Corporation
11.12.1 Epic Systems Corporation Company Details
11.12.2 Epic Systems Corporation Business Overview
11.12.3 Epic Systems Corporation Virtual Oncology Introduction
11.12.4 Epic Systems Corporation Revenue in Virtual Oncology Business (2020-2025)
11.12.5 Epic Systems Corporation Recent Development
11.13 Optum, Inc
11.13.1 Optum, Inc Company Details
11.13.2 Optum, Inc Business Overview
11.13.3 Optum, Inc Virtual Oncology Introduction
11.13.4 Optum, Inc Revenue in Virtual Oncology Business (2020-2025)
11.13.5 Optum, Inc Recent Development
11.14 CureMatch, Inc.
11.14.1 CureMatch, Inc. Company Details
11.14.2 CureMatch, Inc. Business Overview
11.14.3 CureMatch, Inc. Virtual Oncology Introduction
11.14.4 CureMatch, Inc. Revenue in Virtual Oncology Business (2020-2025)
11.14.5 CureMatch, Inc. Recent Development
11.15 Oncora Medical
11.15.1 Oncora Medical Company Details
11.15.2 Oncora Medical Business Overview
11.15.3 Oncora Medical Virtual Oncology Introduction
11.15.4 Oncora Medical Revenue in Virtual Oncology Business (2020-2025)
11.15.5 Oncora Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Virtual Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Software
Table 3. Key Players of Service
Table 4. Key Players of Hardware
Table 5. Global Virtual Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Virtual Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Virtual Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Virtual Oncology Market Share by Region (2020-2025)
Table 9. Global Virtual Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Virtual Oncology Market Share by Region (2026-2031)
Table 11. Virtual Oncology Market Trends
Table 12. Virtual Oncology Market Drivers
Table 13. Virtual Oncology Market Challenges
Table 14. Virtual Oncology Market Restraints
Table 15. Global Virtual Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Virtual Oncology Market Share by Players (2020-2025)
Table 17. Global Top Virtual Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Oncology as of 2024)
Table 18. Ranking of Global Top Virtual Oncology Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Virtual Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Virtual Oncology, Headquarters and Area Served
Table 21. Global Key Players of Virtual Oncology, Product and Application
Table 22. Global Key Players of Virtual Oncology, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Virtual Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Virtual Oncology Revenue Market Share by Type (2020-2025)
Table 26. Global Virtual Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Virtual Oncology Revenue Market Share by Type (2026-2031)
Table 28. Global Virtual Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Virtual Oncology Revenue Market Share by Application (2020-2025)
Table 30. Global Virtual Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Virtual Oncology Revenue Market Share by Application (2026-2031)
Table 32. North America Virtual Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Virtual Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Virtual Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Virtual Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Virtual Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Virtual Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Virtual Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Virtual Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Virtual Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Virtual Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Virtual Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Virtual Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Virtual Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Virtual Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Virtual Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 47. McKesson Corporation Company Details
Table 48. McKesson Corporation Business Overview
Table 49. McKesson Corporation Virtual Oncology Product
Table 50. McKesson Corporation Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 51. McKesson Corporation Recent Development
Table 52. Cerner Corporation Company Details
Table 53. Cerner Corporation Business Overview
Table 54. Cerner Corporation Virtual Oncology Product
Table 55. Cerner Corporation Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 56. Cerner Corporation Recent Development
Table 57. Koninklijke Philips N.V. Company Details
Table 58. Koninklijke Philips N.V. Business Overview
Table 59. Koninklijke Philips N.V. Virtual Oncology Product
Table 60. Koninklijke Philips N.V. Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 61. Koninklijke Philips N.V. Recent Development
Table 62. Siemens Healthcare Private Limited Company Details
Table 63. Siemens Healthcare Private Limited Business Overview
Table 64. Siemens Healthcare Private Limited Virtual Oncology Product
Table 65. Siemens Healthcare Private Limited Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 66. Siemens Healthcare Private Limited Recent Development
Table 67. Crisp Company Details
Table 68. Crisp Business Overview
Table 69. Crisp Virtual Oncology Product
Table 70. Crisp Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 71. Crisp Recent Development
Table 72. Varian Medical Systems, Inc. Company Details
Table 73. Varian Medical Systems, Inc. Business Overview
Table 74. Varian Medical Systems, Inc. Virtual Oncology Product
Table 75. Varian Medical Systems, Inc. Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 76. Varian Medical Systems, Inc. Recent Development
Table 77. Elekta AB Company Details
Table 78. Elekta AB Business Overview
Table 79. Elekta AB Virtual Oncology Product
Table 80. Elekta AB Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 81. Elekta AB Recent Development
Table 82. Accuray Incorporated Company Details
Table 83. Accuray Incorporated Business Overview
Table 84. Accuray Incorporated Virtual Oncology Product
Table 85. Accuray Incorporated Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 86. Accuray Incorporated Recent Development
Table 87. C-TAC Health Company Details
Table 88. C-TAC Health Business Overview
Table 89. C-TAC Health Virtual Oncology Product
Table 90. C-TAC Health Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 91. C-TAC Health Recent Development
Table 92. Oscar Health Company Details
Table 93. Oscar Health Business Overview
Table 94. Oscar Health Virtual Oncology Product
Table 95. Oscar Health Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 96. Oscar Health Recent Development
Table 97. NXGN Management, LLC Company Details
Table 98. NXGN Management, LLC Business Overview
Table 99. NXGN Management, LLC Virtual Oncology Product
Table 100. NXGN Management, LLC Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 101. NXGN Management, LLC Recent Development
Table 102. Epic Systems Corporation Company Details
Table 103. Epic Systems Corporation Business Overview
Table 104. Epic Systems Corporation Virtual Oncology Product
Table 105. Epic Systems Corporation Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 106. Epic Systems Corporation Recent Development
Table 107. Optum, Inc Company Details
Table 108. Optum, Inc Business Overview
Table 109. Optum, Inc Virtual Oncology Product
Table 110. Optum, Inc Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 111. Optum, Inc Recent Development
Table 112. CureMatch, Inc. Company Details
Table 113. CureMatch, Inc. Business Overview
Table 114. CureMatch, Inc. Virtual Oncology Product
Table 115. CureMatch, Inc. Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 116. CureMatch, Inc. Recent Development
Table 117. Oncora Medical Company Details
Table 118. Oncora Medical Business Overview
Table 119. Oncora Medical Virtual Oncology Product
Table 120. Oncora Medical Revenue in Virtual Oncology Business (2020-2025) & (US$ Million)
Table 121. Oncora Medical Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Virtual Oncology Picture
Figure 2. Global Virtual Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Virtual Oncology Market Share by Type: 2024 VS 2031
Figure 4. Software Features
Figure 5. Service Features
Figure 6. Hardware Features
Figure 7. Global Virtual Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Virtual Oncology Market Share by Application: 2024 VS 2031
Figure 9. Hospitals & Diagnostic Imaging Centers Case Studies
Figure 10. Academic Institutions & Research Centers Case Studies
Figure 11. Pharma & Biotech Companies Case Studies
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Others Case Studies
Figure 14. Virtual Oncology Report Years Considered
Figure 15. Global Virtual Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Virtual Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Virtual Oncology Market Share by Region: 2024 VS 2031
Figure 18. Global Virtual Oncology Market Share by Players in 2024
Figure 19. Global Top Virtual Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Oncology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Virtual Oncology Revenue in 2024
Figure 21. North America Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Virtual Oncology Market Share by Country (2020-2031)
Figure 23. United States Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Virtual Oncology Market Share by Country (2020-2031)
Figure 27. Germany Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Virtual Oncology Market Share by Region (2020-2031)
Figure 35. China Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Virtual Oncology Market Share by Country (2020-2031)
Figure 43. Mexico Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Virtual Oncology Market Share by Country (2020-2031)
Figure 47. Turkey Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Virtual Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. McKesson Corporation Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 51. Cerner Corporation Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 52. Koninklijke Philips N.V. Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 53. Siemens Healthcare Private Limited Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 54. Crisp Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 55. Varian Medical Systems, Inc. Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 56. Elekta AB Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 57. Accuray Incorporated Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 58. C-TAC Health Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 59. Oscar Health Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 60. NXGN Management, LLC Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 61. Epic Systems Corporation Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 62. Optum, Inc Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 63. CureMatch, Inc. Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 64. Oncora Medical Revenue Growth Rate in Virtual Oncology Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
